These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

669 related items for PubMed ID: 31410540

  • 1. Non-invasive prediction of IDH-wildtype genotype in gliomas using dynamic 18F-FET PET.
    Vettermann F, Suchorska B, Unterrainer M, Nelwan D, Forbrig R, Ruf V, Wenter V, Kreth FW, Herms J, Bartenstein P, Tonn JC, Albert NL.
    Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2581-2589. PubMed ID: 31410540
    [Abstract] [Full Text] [Related]

  • 2. Static 18F-FET PET and DSC-PWI based on hybrid PET/MR for the prediction of gliomas defined by IDH and 1p/19q status.
    Song S, Wang L, Yang H, Shan Y, Cheng Y, Xu L, Dong C, Zhao G, Lu J.
    Eur Radiol; 2021 Jun; 31(6):4087-4096. PubMed ID: 33211141
    [Abstract] [Full Text] [Related]

  • 3. Comparison of 18F-GE-180 and dynamic 18F-FET PET in high grade glioma: a double-tracer pilot study.
    Unterrainer M, Fleischmann DF, Diekmann C, Vomacka L, Lindner S, Vettermann F, Brendel M, Wenter V, Ertl-Wagner B, Herms J, Wetzel C, Rupprecht R, Tonn JC, Belka C, Bartenstein P, Niyazi M, Albert NL.
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):580-590. PubMed ID: 30244386
    [Abstract] [Full Text] [Related]

  • 4. Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-L-tyrosine PET.
    Bauer EK, Stoffels G, Blau T, Reifenberger G, Felsberg J, Werner JM, Lohmann P, Rosen J, Ceccon G, Tscherpel C, Rapp M, Sabel M, Filss CP, Shah NJ, Neumaier B, Fink GR, Langen KJ, Galldiks N.
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1486-1495. PubMed ID: 32034446
    [Abstract] [Full Text] [Related]

  • 5. Static and dynamic 18F-FET PET for the characterization of gliomas defined by IDH and 1p/19q status.
    Verger A, Stoffels G, Bauer EK, Lohmann P, Blau T, Fink GR, Neumaier B, Shah NJ, Langen KJ, Galldiks N.
    Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):443-451. PubMed ID: 29043400
    [Abstract] [Full Text] [Related]

  • 6. Characterization of Diffuse Gliomas With Histone H3-G34 Mutation by MRI and Dynamic 18F-FET PET.
    Vettermann FJ, Felsberg J, Reifenberger G, Hasselblatt M, Forbrig R, Berding G, la Fougère C, Galldiks N, Schittenhelm J, Weis J, Albert NL, Schüller U.
    Clin Nucl Med; 2018 Dec; 43(12):895-898. PubMed ID: 30358620
    [Abstract] [Full Text] [Related]

  • 7. 18F-FET PET prior to recurrent high-grade glioma re-irradiation-additional prognostic value of dynamic time-to-peak analysis and early static summation images?
    Fleischmann DF, Unterrainer M, Bartenstein P, Belka C, Albert NL, Niyazi M.
    J Neurooncol; 2017 Apr; 132(2):277-286. PubMed ID: 28102485
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [18F]FET PET, and TSPO PET.
    Kaiser L, Quach S, Zounek AJ, Wiestler B, Zatcepin A, Holzgreve A, Bollenbacher A, Bartos LM, Ruf VC, Böning G, Thon N, Herms J, Riemenschneider MJ, Stöcklein S, Brendel M, Rupprecht R, Tonn JC, Bartenstein P, von Baumgarten L, Ziegler S, Albert NL.
    Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2371-2381. PubMed ID: 38396261
    [Abstract] [Full Text] [Related]

  • 16. The diagnostic accuracy of detecting malignant transformation of low-grade glioma using O-(2-[18F]fluoroethyl)-l-tyrosine positron emission tomography: a retrospective study.
    Bashir A, Brennum J, Broholm H, Law I.
    J Neurosurg; 2018 Apr 06; 130(2):451-464. PubMed ID: 29624154
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. IDH mutation is paradoxically associated with higher 18F-FDOPA PET uptake in diffuse grade II and grade III gliomas.
    Verger A, Metellus P, Sala Q, Colin C, Bialecki E, Taieb D, Chinot O, Figarella-Branger D, Guedj E.
    Eur J Nucl Med Mol Imaging; 2017 Aug 06; 44(8):1306-1311. PubMed ID: 28293705
    [Abstract] [Full Text] [Related]

  • 19. Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas.
    Röhrich M, Huang K, Schrimpf D, Albert NL, Hielscher T, von Deimling A, Schüller U, Dimitrakopoulou-Strauss A, Haberkorn U.
    Eur J Nucl Med Mol Imaging; 2018 Jul 06; 45(9):1573-1584. PubMed ID: 29732524
    [Abstract] [Full Text] [Related]

  • 20. Integration of dynamic parameters in the analysis of 18F-FDopa PET imaging improves the prediction of molecular features of gliomas.
    Ginet M, Zaragori T, Marie PY, Roch V, Gauchotte G, Rech F, Blonski M, Lamiral Z, Taillandier L, Imbert L, Verger A.
    Eur J Nucl Med Mol Imaging; 2020 Jun 06; 47(6):1381-1390. PubMed ID: 31529264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.